Rice, Potatoes, and Grains: Why Did Carbs Get Such a Bad Reputation? (Copy)
Metabolic Syndrome: Can You Have It at Any Body Size?
If you read my recent article about metabolic syndrome, you may remember that it isn't one disease or one number.Metabolic syndrome is a cluster of five health factors: elevated blood glucose, high triglycerides, low HDL cholesterol, elevated blood pressure, and increased waist circumference. Having three or more of these factors is generally used to identify metabolic syndrome and increased cardiometabolic risk.But there is an important point that doesn’t often get addressed:Can you have metabolic syndrome if you aren't in a larger body?Yes.And the flip side is also important:Can someone in a larger body have healthy metabolic measures?Yes.That's because metabolic health is more complex than body size alone.
Metabolic Health FAQ
Can you have metabolic syndrome at any body size?
Yes. Metabolic syndrome can occur in people of any body size. Body size alone does not determine whether someone has the blood pressure, blood glucose, triglyceride, HDL cholesterol, or waist circumference risk factors associated with metabolic syndrome.
Can a thin person have metabolic syndrome?
Yes. A person in a smaller body can have high blood pressure, elevated blood glucose, high triglycerides, low HDL cholesterol, or other metabolic risk factors. Metabolic problems aren't always visible.
Can someone with obesity be metabolically healthy?
Yes. Some people with obesity do not currently have the metabolic risk factors associated with metabolic syndrome. However, metabolic health can change over time, so regular health monitoring is still important.
Does BMI determine metabolic health?
No. BMI can provide useful information about body size, but it does not measure blood pressure, blood glucose, cholesterol, triglycerides, insulin resistance, or overall metabolic health. These factors need to be assessed directly.
What tests measure metabolic health?
There isn't one single test. Depending on your individual health history, relevant measures can include blood pressure, fasting blood glucose or A1C, triglycerides, HDL cholesterol, other lipid measurements, and waist circumference.
What does Health at Every Size mean?
Health at Every Size, or HAES®, is a weight-inclusive approach that recognizes that health and healthy behaviors are possible across a range of body sizes. It emphasizes respectful health care, reducing weight stigma, supporting sustainable health behaviors, and recognizing that body size does not tell us everything about a person's health.
Does HAES® mean everyone is healthy?
No. HAES® does not mean that every person is healthy or that health conditions should be ignored. It means that health should be assessed based on actual health measures and individual circumstances rather than assumed from someone's body size.
Metabolic Risk Isn't Determined by Body Size Alone
Body size can be associated with certain health risks, but it doesn't tell us what is actually happening inside someone's body.
Two people can have the same BMI and very different blood pressure, blood glucose, triglycerides, HDL cholesterol, fitness levels, sleep, family history, and other health factors.
The same is true in the other direction. Two people with very different body sizes can have similar metabolic measurements.
This is one reason I don't think it's appropriate to look at someone's body and make assumptions about their health.
If we're concerned about metabolic health, we should actually look at metabolic health.
That means checking the things that tell us something about it.
Larger Bodies Can Be Metabolically Healthy
Yes, people in larger bodies can have healthy blood pressure, blood glucose, triglycerides, and HDL cholesterol.
You will sometimes see the phrase "metabolically healthy obesity" used in research to describe people who meet criteria for obesity based on BMI but don't currently have certain metabolic abnormalities.
There is an important caveat here.
Metabolic health can change over time. Not just can change but often does change as we age. Research has found that some people who initially have a favorable metabolic profile later develop metabolic risk factors, which is one reason it makes sense to monitor health rather than assume that a particular body size automatically means either health or disease.
In other words, a larger body can be metabolically healthy, but that doesn't mean metabolic risk doesn't exist.
It means we shouldn't assume risk simply by looking at someone's body.
Smaller Bodies Can Have Metabolic Risk, Too
This part is often overlooked. Or ignored.
Someone can have a smaller body and still have high blood pressure, elevated blood glucose, high triglycerides, or low HDL cholesterol.
They can also develop insulin resistance, type 2 diabetes, cardiovascular disease, or metabolic syndrome.
That's why the phrase "You don't look like you have a metabolic problem" is both ridiculous and inappropriate.
Metabolic problems aren't always visible.
Some of the factors that make up metabolic syndrome don't have obvious symptoms, which is another reason routine health care and appropriate screening matter.
Why Weight Alone Isn't Enough
Weight and BMI can provide information, but neither tells us the whole story about metabolic health.
If your goal is to understand cardiometabolic risk, more direct measures are available.
Depending on your individual circumstances, your health care provider may monitor things such as:
Blood pressure
Fasting blood glucose or A1c
Triglycerides
HDL cholesterol
Other cholesterol measurements
Waist circumference
Family history
Physical activity and fitness
Other relevant health conditions and medications
These measurements give us information that a scale cannot provide.
That doesn't make body weight irrelevant. It means weight is one piece of information, not the entire health assessment.
Where Does Health at Every Size Fit?
You may have heard about Health at Every Size, or HAES®.
HAES® (pronounced “hayes”) is a weight-inclusive approach that emphasizes health behaviors, access to respectful health care, body acceptance, and reducing weight stigma rather than making weight loss the only measure of success.
And I want to be clear about something because HAES® is sometimes misunderstood.
Health at Every Size does not mean that every body is automatically healthy.
It does not mean that body size has no relationship to health.
It does not mean we ignore high blood pressure, elevated blood glucose, abnormal cholesterol, or other health concerns because someone is in a larger body.
It means health is possible across a range of body sizes, and we should not assume someone's health status based on size alone.
That distinction is important and sometimes misunderstood.
Evidence on HAES®-based interventions is still developing. A 2024 systematic review and meta-analysis found that HAES® interventions produced similar cardiometabolic outcomes to comparison approaches, with a significant benefit related to susceptibility to hunger, but the researchers also noted limitations in the evidence and the need for more research.
That is a much more useful way to talk about HAES® than either declaring it the answer to everything or dismissing it outright.
There is also good reason to take weight stigma seriously. Research has associated weight stigma with adverse physical and psychological outcomes, and more recent professional guidance emphasizes the importance of recognizing and addressing weight bias in health care. Weight bias in health care is a significant issue.
Have Things Changed In the "Ozempic Era"?
More recently, this topic/approach has become more complicated as medications such as semaglutide and other GLP-1 medications have become much more common.
This is where I think we need to consider the details.
These medications are not simply "bad" or "good."
Legitimate evidence shows that some GLP-1 medications can provide clinically meaningful benefits for people who meet appropriate medical criteria. For example, the SELECT trial found that semaglutide reduced major cardiovascular events in adults with established cardiovascular disease and overweight or obesity who did not have diabetes.
That is meaningful evidence, and it shouldn't be dismissed.
At the same time, the growing focus on weight-loss medications can reinforce the idea that a smaller body is automatically healthier, or that weight loss should be the goal for everyone.
Neither conclusion is supported by the evidence.
Treatment decisions should be based on an individual's health, risk factors, medical history, preferences, and goals. Current clinical guidance also supports using obesity pharmacotherapy as part of individualized care rather than treating medication as a universal solution.
Whether someone uses a GLP-1 medication, pursues weight loss, maintains their current weight, or takes a different approach, metabolic health must still be assessed on its own terms.
Let's Focus on the Health, Not Just the Size
If someone has metabolic syndrome, the important question isn't simply, "How much do they weigh?"
The questions we should be addressing are:
What is happening with their blood pressure?
What do their glucose and A1C show?
What are their triglycerides and HDL cholesterol?
What other risk factors are present?
What can we do to support their health?
And just as importantly, how can we address those things without shame?
A person in a larger body deserves access to appropriate screening, nutrition care, physical activity, medical treatment, and respectful health care.
A person in a smaller body deserves the same.
Neither person should have their health assumed based on appearance.
Metabolic syndrome is about metabolic risk. So let's actually look at the metabolic risk.
That's a much more appropriate approach than simply deciding whether someone's body looks "healthy."
Sources and further reading:
American Heart Association:
NIH National Library of Medicine National Center for Biotechnology Information:
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. PMID: 40789597; PMCID: PMC12350384.
Revisiting the impact of Health at Every Size® interventions on health and cardiometabolic related outcomes: An updated systematic review with meta-analysis. Nutr Diet. PMID: 38563692.
SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. PMID: 37952131.
Metabolic health and adiposity transitions and risks of type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis. PMID: 36973730; PMCID: PMC10045173.
Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: A systematic review. PMID: 29171076.
Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. PMID: 26286585.
